Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
COVID-19 - Coprobacillus |
📓
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal transduction and targeted therapy (Signal Transduct Target Ther ) Vol: 7 Issue 1 Pages: 143 Pub: 2022 Apr 29 Epub: 2022 Apr 29 Authors Wang B , Zhang L , Wang Y , Dai T , Qin Z , Zhou F , Zhang L , Publication |
COVID-19 - Coprobacillus |
📓
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology (Gastroenterology ) Vol: 159 Issue 3 Pages: 944-955.e8 Pub: 2020 Sep Epub: 2020 May 20 Authors Zuo T , Zhang F , Lui GCY , Yeoh YK , Li AYL , Zhan H , Wan Y , Chung ACK , Cheung CP , Chen N , Lai CKC , Chen Z , Tso EYK , Fung KSC , Chan V , Ling L , Joynt G , Hui DSC , Chan FKL , Chan PKS , Ng SC , Publication |
COVID-19 - Coprobacillus |
📓
Gut Microbiome Alterations in COVID-19. Genomics, proteomics & bioinformatics (Genomics Proteomics Bioinformatics ) Vol: Issue Pages: Pub: 2021 Sep 21 Epub: 2021 Sep 21 Authors Zuo T , Wu X , Wen W , Lan P , Publication |
COVID-19 - Coprobacillus |
📓
Microbiota and COVID-19: Long-term and complex influencing factors. Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 963488 Pub: 2022 Epub: 2022 Aug 12 Authors Gang J , Wang H , Xue X , Zhang S , Publication |
COVID-19 - Coprobacillus |
📓
Gut microbiota in COVID-19: new insights from inside. Gut microbes (Gut Microbes ) Vol: 15 Issue 1 Pages: 2201157 Pub: 2023 Jan-Dec Epub: Authors Zhou B , Pang X , Wu J , Liu T , Wang B , Cao H , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.